Fundraising Fox

Zafrens

San Diego, US · Founded 2021 · Delaware corporation · 8 known investors

zafrens.com ↗

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities. The platform leverages AI and high-resolution data to compress timelines in drug development.

AI & Machine LearningBiotechDeep Techin /zafrens

Founders & leadership

MSMartin Smrcina
Martin Smrcinain
MNMaina Ndungu
Maina Ndunguin
SVSwamy Vijayan
Swamy VijayaninExecutive Officer, Director
YZYi Zhang
Yi Zhangin
VGVikas Goel
Vikas Goelin
JBJustin Briggs
Justin Briggsin

Investors · 8

Acequia Capital (AceCap)Seattle · $100K – $5M
Global BrainTokyo · $100K – $184M
Iaso VenturesCambridge
Raptor GroupMiami Beachvia Jim Pallotta · inferred
BlueYard CapitalreportedBerlin · $500K – $5M
FoundersX VenturesreportedSilicon Valley
imec.xpandreported · 2 sourcesLeuven · $270K – $5.4M
Prime Movers Labreported · 2 sourcesJackson · $2M – $30M

Reported raises · per SEC filings

Form D private placements
▶$6.2MraisedJan 2022 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kandaswamy VijayanExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news